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The cathelicidin-derived antimicrobial tritrpticin could be classified as either Trp-rich or Pro/Arg-rich peptide. We recently found that the
sequence modification of tritrpticin focused on Trp and Pro residues led to considerable change in structure and antimicrobial potency and selectivity,
but their mechanisms of microbial killing action were still unclear. Here, to better understand the bactericidal mechanisms of tritrpticin and its two
analogs, TPA and TWF, we studied their effect on the viability of Gram-positive S. aureus and Gram-negative E. coli in relation to their membrane
depolarization. Although TWF more effectively inhibited growth of S. aureus and E. coli than TPA, only a 30 min exposure to TPAwas sufficient to
kill both bacteria and TWF required a lag period of about 3–6 h for bactericidal activity. Their different bactericidal kinetics was associated with
membrane permeabilization, i.e., TWF showed negligible ability to depolarize the cytoplasmic membrane potential of target cell membrane, whereas
we observed significant membrane depolarization for TPA. In addition, while TPA caused rapid and large dye leakage from negatively chargedmodel
vesicles, TWF showed very little membrane-disrupting activity. Interestingly, we have looked for a synergism among the three peptides against E.
coli, supporting that they are working with different modes of action. Collectively, our results suggest that TPA disrupts the ion gradients across the
membrane, causing depolarization and a loss of microbial viability. By contrast, TWF more likely translocates across the cytoplasmic membrane
without depolarization and then acts against one or more intracellular targets. Tritrpticin exhibits intermediate properties and appears to act via
membrane depolarization coupled to secondary intracellular targeting.
© 2006 Elsevier B.V. All rights reserved.Keywords: Cathelicidin; Tritrpticin; Membrane depolarization; Intracellular target; Synergy1. Introduction
In mammals, endogenous antimicrobial peptides are small
molecules that have the capacity to kill and/or inhibit a broad
range of microorganisms, including Gram-positive and Gram-
negative bacteria and fungi [1–4]. The primary and secondary
granules of neutrophils contain a variety of these peptides, which
represent important components of the innate host defense [5,6].Abbreviations: PP-II, polyproline type II; CD, circular dichroism; MIC,
minimal inhibitory concentration; FIC, fractional inhibitory concentration;
CFU, colony forming units; diSC3(5), 3,3′-dipropylthiacarbocyanine; LPS,
lipopolysaccharide; POPC, 1-palmitoyl-2-oleoyl-phosphatidylcholine; POPG,
1-palmitoyl-2-oleoyl-phosphatidylglycerol; LUVs, large unilamellar vesicles;
SDS, sodium dodecyl sulfate
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doi:10.1016/j.bbamem.2006.06.007One major class of these peptides, the cathelicidins, appears to be
expressed in response to cytokines produced early during infec-
tion [7–9]. Endogenous cathelicidins share strongly conservedN-
terminal pre-proregions and highly varied C-terminal domains,
which correspond to their antimicrobial properties. Two hypoth-
eses have been proposed to explain the mechanism of antimicro-
bial action of cathelicidin-derived peptides: some appear to have
the ability to permeabilize the microbial cytoplasmic membranes,
while others appear to cross the cell membrane and interact with
intracellular targets [10–12]. For example, BMAP-27 [13] and
PMAP-23 [14], amphipathic α-helical peptides, are membrane-
active and kill microorganisms through membrane permeabiliza-
tion. By contrast, PR-39 [15] and Bac7 [16], Pro-rich peptides are
not linked tomembrane disruption and both inhibit bacterial DNA
synthesis or cause a rapid reduction inRNA and protein synthesis.
The cathelicidin-derived antimicrobial peptide tritrpticin, which
was first identified through screening a porcine bone marrow
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when bound to SDS micelles [18]. The primary structure of
tritrpticin is remarkable by virtue of its high content of Arg, Trp
and Pro residues, which are crucial for its interaction with phos-
pholipids. Several studies aimed at clarifying the antimicrobial
action of tritrpticin have been carried out, but their results reveal
no consistent mechanism. In one study Nagpal et al. [19] pro-
posed that tritrpticin adopts a β-turn structure in aqueous buffer
and undergoes functional activation through a conformational
transition as an initial event in bacterial killing. By contrast,
Schibli et al. [18] reported that while tritrpticin shows a disordered
structure in Tris–HCl buffer, the peptide adopts an amphipathic
turn structure in SDS micelles, so that its antibacterial action
might involve nonspecific interactions with the cell membrane.
In addition, the results of a recent electrophysiological study by
Salay et al. [20] suggested that tritrpticin has channel-like activity
in azolectin planar lipid bilayers. Since there is much ambiguity
concerning the mode of action of tritrpticin, it is of interest to
clarify the structure-dependent membrane interaction and mode
of antimicrobial action. In a recent study, we reported that ap-
parent differences in their CD patterns induced by modifying the
sequence of tritrpticin are closely related to pronounced changes
in the molecule's activity and selectivity [21]. For example, the
analog TPA, substituting the two Pro residues with Ala, adopted
an α-helical structure, but not amphipathic turn structure, and
exerted a slightly reduced antibacterial potency. In contrast, the
analog TWF, in which Trp was replaced with Phe, showed a 2- to
4-fold increase in antimicrobial activity against Gram-negative
bacteria and was as active as tritrpticin against Gram-positive
bacteria. On the other hand, it showed significantly reduced ac-
tivity against human erythrocytes, suggesting it is largely that Trp
in somewaymediates erythrocyte damage by these peptides. Still,
the mechanisms of antimicrobial action of tritrpticin and its two
analogs (TWF and TPA) remain unclear.
Here, we carried out a systematic analysis of the effects
tritrpticin, TWF, and TPA on the viability of Gram-positive Sta-
phylococcus aureus and Gram-negative Escherichia coli, with
the aim of better understanding their diverse mechanisms of ac-
tion and providing a structural basis for the design of efficient
low-molecular-weight peptide antibiotics.
2. Experimental procedures
2.1. Bacterial killing assays
Gram-positive Staphylococcus aureus (KCTC 1621) and
Gram-negative Escherichia coli (KCTC 1682) were grown to
mid-log phase at 37 °C in Luria Bertani medium. The cells were
washed twice with 10 mM phosphate buffer (pH 7.4) and resus-
pended in the same buffer to give approximately 2×106 colony
forming units (CFU)/ml. Peptides were then added to give a
64 μg/ml peptide concentration and 106 CFU/ml. This mixture
was incubated at 37 °C, and the viabilities of the cells were
estimated at timed intervals. After 200-fold dilution with 10 mM
phosphate buffer, 100 μl aliquots were spread on heart infusion
agar plates and incubated for 20 h to allow full colony develop-
ment. The resultant colonies were counted and the killing rate wasdetermined by plotting the log CFU/ml against time. The results
of three independent experiments were averaged.
2.2. Membrane depolarization assay
Measurements of cytoplasmic membrane depolarization
were made using a membrane potential-sensitive probe, 3,3′-
dipropylthiacarbocyanine [diSC3(5)] as previously reported
[22]. Staphylococcus aureus and E. coli cells were grown at
37 °C to mid-log phase, centrifuged (3500 rpm, 7 min) and
washed with 5 mM HEPES buffer (pH 7.2) containing 20 mM
glucose and resuspended in buffer (5 mMHEPES buffer, 20 mM
glucose, 100 mM KCl, pH 7.2) to an OD600 of 0.05. Changes in
fluorescence due to the collapse of the cytoplasmic mem-
brane potential were continuously monitored at 20 °C using a
Shimadzu RF-5301 spectrofluorometer at an excitation wave-
length of 622 nm and an emission wavelength of 670 nm. When
the dye uptake was maximal, as indicated by a stable reduction
in fluorescence due to quenching of the accumulated dye in the
membrane interior, peptides were added to the cells. Complete
collapse of the membrane potential for S. aureus and E. coli
was obtained using gramicidin D (0.22 nM), which forms ion
channels in the cytoplasmic membrane of both bacteria, thereby
dissipating themembranepotential.Measurementswere repeated
two times under each condition to ensure reproducibility.
2.3. Peptide-induced dye leakage from large unilamellar vesicles
Large unilamellar vesicles (LUVs) within which dye was
entrapped were prepared by hydrating a POPC/POPG (2:1)
mixture with dye solution (70 mM calcein, 10 mMTris, 150 mM
NaCl, 0.1 mM EDTA, pH 7.4) as previously described [23]. The
mixed solution was put through five freeze–thaw cycles and
then extruded 20 times through polycarbonate filters (Liposo-
Fast; pore diameter, 100 nm). Untrapped dye was then removed
by gel filtration chromatography on a Sephadex G-50 column.
The fluorescence intensity of the calcein released from the vesi-
cles was monitored at 520 nm (excited at 490 nm) on a Shimadzu
RF-5301 spectrofluorometer. To obtain 100% leakage, 10% w/v
Triton X-100 (20 μl) was added to dissolve the vesicles. Mea-
surements were repeated three times under each condition.
2.4. Synergistic activity
To examine the synergistic actions of tritrpticin and its analogs,
the peptides and bacteria (106 CFU/ml) were incubated in 10 mM
phosphate buffer (pH 7.4) for 15 min at 37 °C and then spread on
agar plates and incubated for 20 h. The resultant colonies were
counted, and synergic effects of the peptides on antibacterial
activity was expressed as killing (%) using the following formula:
killing (%)=[1− (number of colonies in the presence of peptides/
number of colonies in the absence of peptides)]×100. The re-
corded killing (%)was the average from three independent assays.
In addition, the fractional inhibitory concentration (FIC) was de-
termined using checkerboard titrations [24], in which one peptide
was diluted (2-fold serial dilution in 1% peptone) along the rows
of 96-well microtiter plates and the other was diluted along the
Table 1
Amino acid sequences of the peptides used in this study and their antimicrobial
activity (MIC: μg/ml)
Peptides Sequence MIC a (μg/ml)
S. aureus E. coli
Tritrpticin VRRFPWWWPFLRR 16 32
TPA VRRFAWWWAFLRR 32 32
TWF VRRFPFFFPFLRR 16 8
a Previously reported data (21).
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well, after which the plates were incubated at 37 °C for 20 h. Cell
growth was then assessed by measuring the OD620 of the cultures
using a microplate reader. The FIC was calculated as follows:
FIC=[A]/MICA+[B]/MICB, where MICA and MICB are the
minimum inhibitory concentrations (MICs) of peptides A and B
alone, respectively, and [A] and [B] are the MICs of peptides A
and B in combination. The MICs of each peptide alone were
recalculated as a control.
3. Results
The sequences of tritrpticin and its two analogs, TPA and
TWF, and their MICs are listed in Table 1. In an attempt to discernFig. 1. Kinetics of the bactericidal effects of tritrpticin (○), TPA (▽) and TWF
(□) on S. aureus (A) and E. coli (B). Bacteria treated with the respective
peptides (64 μg/ml) were diluted at the indicated times and then plated on LB
agar. The CFUs were then counted after 20 h of incubation at 37 °C.differences in themechanisms bywhich these three peptides exert
their lethal effects, we initially measured the kinetics of their
bactericidal effects against S. aureus and E. coli, as representative
of Gram-positive and Gram-negative bacteria, respectively. We
then employed intact and model membranes and examined the
peptide–membrane interaction, and finally investigated their
ability to interact synergistically with one another.
3.1. Kinetics of the bactericidal activities of tritrpticin, TPA and
TWF
Fig. 1 shows the time-dependent decline in the number of
surviving cells (CFUs/ml) with incubation in the presence of each
peptide. There was little difference in the rates at which each
peptide killed S. aureus (Fig. 1A) and E. coli (Fig. 1B), but there
were considerable differences in the respective kinetics among the
three peptides. At the same concentration (64 μg/ml), TPA and
tritrpticin almost completely killed both bacteria within 30 min
and 60 min, respectively. By contrast, TWF had no immediate
impact; numbers of CFUs were reduced by less than 2 log after
30 min of incubation. TWF required 3–6 h to fully exert its
bactericidal effect (data not shown). This is despite the fact that in
growth inhibition experiments, TWF acted similarly or more
effectively against both S. aureus and E. coli than either tritrpticin
or TPA (Table 1). Thus, the bactericidal kineticswere independent
of the antimicrobial activities (MICs) of the peptides.
3.2. Membrane depolarization
To determine the extent to which permeabilization of the cy-
toplasmic membrane contributed to the antimicrobial activity of
the peptides, we evaluated their ability to disrupt S. aureus and E.
coli cytoplasmic membranes using the membrane potential-
sensitive dye diSC3(5). Upon addition of the dye to a suspensions
of S. aureus, its fluorescence was strongly quenched as it enteredFig. 2. Membrane depolarization of intact S. aureus by tritrpticin (○), TPA (▽)
and TWF (□). Once the fluorescence had stabilized after addition of the
membrane potential-sensitive dye diSC3(5) (20 nM) to suspensions of S.
aureus cells (OD600=0.05), the peptides (1 μg/ml) were added. Gramicidin D
(0.22 nM) was used to fully collapse of the membrane potential.
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(Fig. 2). For this assay, we previously used membrane active
magainin II and intracellular-acting buforin II as positive and
negative controls [25]. On the other hand, no such accumulation
within the cytoplasmic membrane was initially seen upon addi-
tion of diSC3(5) to suspensions of E. coli, presumably because it
was unable to reach the cytoplasmic membrane due to interfer-
ence by the outer membrane. The outer membrane of Gram-
negative bacteria forms an effective barrier comprised of a stable
complex of lipopolysaccharide and divalent cations such as Ca2+
and Mg2+. We therefore used the metal ion chelator EDTA (final
concentration, 15 mM) to attack the binding sites of the divalent
cations, which effectively disrupted the organization of the outer
membrane, enabling the dye to reach the cytoplasmic membrane
(Fig. 3A). Subsequent addition of peptides resulted in an increase
in diSC3(5) fluorescence reflecting the membrane depolarization,
after which addition of gramicidin D fully collapsed the mem-
brane potential (Fig. 3B). Interestingly, the peptides showed con-
siderable differences in this assay. TPA depolarized both S.Fig. 3. Effect of tritrpticin (○), TPA (▽) and TWF (□) on the membrane
potential of intact E. coli. diSC3(5) fluorescence was measured as described in
Experimental procedures. (A) Concentration-dependent effect of EDTA, which
was used to disrupt the outer membrane of E. coli, so that diSC3(5) could reach
the cytoplasmic membrane. A final concentration of 15 mM was used for
experimentation. (B) Effects of the peptides (2 and 4 μg/ml) added to
suspensions of E. coli cells (OD600=0.05) after addition of EDTA. Gramicidin
D was used to fully collapse the membrane potential.
Fig. 4. Time-dependent and dose-dependent peptide-induced release of calcein
from POPC/POPG (2:1) LUVs. (A) Peptide (4 μg/ml) was added into 70 μM
POPC/POPG (2:1) LUVs, after which leakage was recorded as a function of the
change of fluorescence. Triton X-100 was used as a control to induce total lysis.
(B) Dose-dependent leakage of calcein from the LUVs was defined as the
percent release after 5 min. Symbols: tritrpticin (○); TPA (▽); TWF (□).aureus and E. coli cells at low concentrations, whereas TWF
showed no ability to depolarize either strain at any concentration.
Indeed, TWF mediated very little membrane permeabilization
even at its MIC (data not shown). Tritrpticin showed intermediate
ability to depolarize bacterial membranes. Therefore, there was no
direct correlation between cytoplasmic membrane depolarization
and MIC values (Table 1), indicating that these peptides might be
able to act via other mechanisms as well.Table 2
Synergy among peptides expressed as the FIC
Species FIC index ([A]/[B]) a
Tritrpticin+TPA Tritrpticin+PWF TPA+PWF
S. aureus 1.0 (8/16) 1.0 (8/8) 1.0 (16/8)
E. coli 0.75 (8/16) 0.5 (8/2) 0.38 (4/2)
a The fractional inhibitory concentration (FIC) index was calculated as
follows: FIC index=[A]/MICA+[B]/MICB, where MICA and MICB are the
respective MICs of peptides A and B alone, and [A] and [B] are the MICs of
peptides A and B in combination. The values in parentheses are the MICs in
combination. The MICs for the peptides alone are as given in Table 1.
Fig. 5. Synergistic effects of Tritrpticin and its analogs. S. aureus (black bar) and
E. coli (gray bar) were incubated with tritrpticin, TPA or TWF, alone (16 μg/ml
each peptide) or in combination (8 μg/ml of each peptide), in 10 mM phosphate
buffer (pH 7.4) for 15 min at 37 °C: a, tritrpticin; b, TPA; c, TWF; d, TPA; e,
tritrpticin+TWF; and f, TPA+TWF. Antibacterial activity is expressed as
killing (%).
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We next characterized the time course of peptide-induced
release of calcein from POPC/POPG (2:1) LUVs and determined
the relative lytic efficiencies by comparison with Triton X-100,
which induced complete disruption (Fig. 4). Consistent with
their respective abilities to depolarize bacterial cell membranes,
TWF (4 μg/ml) induced little or no calcein release from LUVs,
whereas TPA (4 μg/ml) showed the greatest membrane-lytic
activity (∼60%). Even at high concentration (16 μg/ml), TWF
had very weak activity against LUVs. These results further con-
firm that, whereas membrane disruption represents a major
killing event for TPA, TWF apparently exerts its bactericidal
effect in some other way. Tritrpticin induced calcein release at a
slower rate than TPA, suggesting the two peptides differ in the
way they interact with negatively-charged membranes.
3.4. Synergistic effects of the peptides on antibacterial activity
Finally, we examined the extent to which tritrpticin and its
analogs are able to act synergistically against S. aureus and E.
coli. Their synergistic effects are expressed in terms of their
fractional inhibitory concentration (FIC) in Table 2 and killing
(%) in Fig. 5. Good synergy (FIC≤0.5) was observedwhen TWF
was applied in combination with either TPA or tritrpticin against
E. coli. By contrast, no such synergistic effect was seen when
tritrpticin and TPA were applied together (FIC=0.75). Only
additive effects (FIC=1.0) were observed against S. aureus. Thus
the combinations of TPA+TWF and tritrpticin+TWF killed E.
coli far more effectively than S. aureus, though the individual
peptides exhibited comparatively low bactericidal activity against
both strains (Fig. 5).
4. Discussion
The primary structure of tritrpticin is remarkable by virtue of
its high Arg (30%), Trp (23%) and Pro (15%) content, and it isthus classified as one of the Trp-rich or Pro/Arg-rich antimicro-
bial peptides. Because Trp, Pro and Arg residues within antimi-
crobial peptides are known to mediate membrane disruption
and/or cell entry [26–29], it seemed appropriate to explore the
mechanism of tritrpticin's antimicrobial action in the context
of its interactions with the bacterial cytoplasmic membrane. In
our previous studies of the structure–activity relationship of
tritrpticin, various modifications of the peptide's sequence elic-
ited distinct structural and functional changes [21,30]. For that
reason, here we evaluated different modes in antimicrobial
action of tritrpticin and its two analogs.
In growth inhibition experiments, TWF acted more effectively
than TPA against both S. aureus and E. coli. In bacterial kill-
ing assays, however, TPA killed bacteria comparatively rapidly
(within 30min), while the same concentration of TWF killed only
after several hours of contact with the bacteria (Fig. 1). In addi-
tion, TPA induced significant membrane depolarization, but TWF
showed virtually no ability to depolarize bacterial membranes
(Figs. 2 and 3). Likewise, TPA induced rapid leakage of calcein
from LUVs, whereas TWF had a negligible effect (Fig. 4). Taken
together, these results strongly suggest that TPA and TWF exert
their bactericidal effects via distinctly different mechanisms of
action. We hypothesize that TPA, which adopts an α-helical
structure, permeabilizes bacterial cytoplasmic membranes, there-
by disrupting the ion gradients across them, killing the cells. By
contrast, TWF more likely crosses the lipid bilayer without per-
meabilizing it and interacts with intracellular targets, as has been
observed with other Pro/Arg-rich peptides. Both the cationic
guanidinium group of Arg residues [29] and the cis-trans iso-
merization in aqueous buffer provided by Pro [18] appear to
facilitate binding to negatively chargedmembranes and improved
membrane translocation, which would in turn facilitate TWF's
access to intracellular targets.
Trp-rich indolicidin is also a member of the cathelicidin family
and has high sequence similarity with tritrpticin. Although the
mechanism for indolicidin has been concluded not to involve
membrane depolarization per se, the peptide strongly interacts
with negatively charged phospholipids [31,32]. An interesting
indolicidin analog CP10A, in which the three Pro residues of
indolicidin were substituted with Ala residues, had a considerably
more amphipathic α-helical structure in membrane mimetic envi-
ronments and showed improved antimicrobial activity against
Gram-positive bacteria [33]. Although electron microscopy
showed minimal effects of the peptide on the cell wall, CP10A
almost complete depolarized the cytoplasmic membrane of S.
aureus at low concentration [33]. An α-helical structure of both
CP10A and TPA is likely to be responsible for causing membrane
depolarization and a rapid loss of microbial viability.
Recently, Yan and Hancock [34] reported that mammalian
peptides from different structural classes frequently act syner-
gistically with one another and suggested that the synergy is
mediated by the cooperative interactions of the peptides with the
outer and/or cytoplasmic membrane of Gram-negative bacteria.
Interestingly, we observed that simultaneous exposure to TPA
and TWF yields a highly synergistic bactericidal effect against
Gram-negative E. coli but not Gram-positive S. aureus (Fig. 5
and Table 2). In addition, our preliminary results showed that α-
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synergistically with Pro/Arg-rich PR-39 (which has an intracel-
lular target) against various Gram-negative pathogens (data not
shown). We therefore suggest that the observed synergism
against E. colimay mean that a certain level of permeabilization
by TPA facilitates the translocation of TWF across the lipid
bilayer, giving it access to its intracellular target. On the other
hand, the resistance of Gram-positive S. aureus to Pro/Arg-rich
peptides likely reflects the ability of the bacterium to express
extracellular proteases that degrade antimicrobial peptides [35].
Tritrpticin has a broad spectrum of antimicrobial activity and
shows an intermediate ability to kill bacteria via depolarization
and to permeabilize model membranes (LUVs). But although
tritrpticin clearly damages target cell membranes, other mech-
anism of action such as secondary intracellular targeting after
cell permeabilization, cannot be excluded. Indeed, recent studies
have shown that indolicidin, which has a sequence similar to that
of tritrpticin, inhibits both DNA and RNA synthesis [31,32].
Although it is not yet clear whether tritrpticin acts in the same
way as indolicidin, tritrpticin does appear to kill microorganisms
via both membrane depolarization and an action against intra-
cellular targets. The proposed dual properties of tritrpticin might
explain the different antimicrobial mechanisms suggested by
Nagpal et al. [19], Schibli et al. [18] and Salay et al. [20]. Addi-
tional studies aimed at better understanding the mechanism by
which Trp-rich peptides are translocated across lipid bilayers are
currently in progress.
In conclusion, tritrpticin, TPA and TWF might well serve as
models with which to gain a better understanding of the rela-
tionship between the structures of antimicrobial peptides and
their mechanisms of action. In addition, given the emergence of
widespread antibiotic resistance, a better understanding of the
conformation-dependency of their bactericidal mechanisms could
facilitate development of new peptide antibiotics that overcome
bacterial resistance by acting synergistically with one another.
Although the mechanism of this synergy remains unclear, the
enhanced efficacy achieved through the combined use of anti-
microbial peptides is likely to be an attractive strategy for treating
infections by Gram-negative pathogens.
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